Jersey City, NJ (PRWEB) May 19, 2015 -- Viora is proud to announce the development of ReFine, a new combination protocol that effectively treats perioral lines. Commonly known as “barcode” lines or wrinkles, these static, vertical lines are caused by a number of factors including genetics, aging, sun exposure and smoking. Typically, the use of fillers and volume corrections is inadequate in the treatment of static lines. A more effective solution is the targeting of the skin and stimulating fibroblast activity. With Viora’s ReFine, practitioners can use the V-ST handpiece to achieve skin tightening, and the V-FR handpiece for skin resurfacing. This treatment combination tightens skin to erase lines, improves skin texture and restores skin elasticity.
Using the V-ST handpiece, driven by proprietary technology, CORE, and the V-FR handpiece, powered by SVC™ the second generation of fractional RF treatments, Viora’s customers can increase their clinic offering, providing an effective, clinically proven solution. The V-ST and V-FR handpieces are accessible with all systems in Viora’s multi-technology platform line (V30 & V20). Neither the V-FR handpiece, nor the ReFine protocol is available in the US.
“Viora is continuously searching for ways to assist our customers in their business, while providing effective, relevant solutions - with our new ReFine protocol, we’ve achieved that,” said Meital Ben-Tovim, General Manager, Viora Ltd. “ReFine offers aesthetic practitioners a better treatment for perioral lines, using an innovative combination of our RF technologies delivered via the V-ST and V-FR handpieces. We’re excited about the potential for our customers, as well as for their patients, with the implementation of this protocol.”
For more information on http://www.vioramed.com/int/applications/refine/ [ReFine __title__ ], visit Viora’s website.
About Viora
Celebrating its 10 year anniversary, Viora is an award-winning medical aesthetics solutions company that’s established in over 65 countries. Viora’s skilled and knowledgeable clinical and technical teams, working with clinicians around the world, have produced innovative, proprietary technologies such as CORE, SVC™ and PCR™. These technologies have revolutionized non-invasive treatments to improve control and increase opportunity for practitioners, while enhancing patient experience in numerous applications. Viora’s in-house expertise has been at the forefront of implementing new developments in response to market demand, improving upon treatments using existing RF and light technologies. Viora builds time machines, so our customers can shape their future. For more information, visit http://www.vioramed.com.
Lisa Appelson, VIORA, http://www.vioramed.com/, +1 (201) 332-4100 Ext: 104, [email protected]
Share this article